Chu; Seung
Patent Applications and Registrations
Patent applications and USPTO patent grants for Chu; Seung.The latest application filed is for "heterodimeric antibodies that bind cd3 and tumor antigens".
Company Profile
16.16.29
- Chu; Seung - Cypress CA
- Chu; Seung - Upland CA
Patent Activity
| Patent | Date |
|---|---|
| Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20220162343 - Bernett; Matthew J. ; et al. | 2022-05-26 |
| Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20220041757 - Bernett; Matthew J. ; et al. | 2022-02-10 |
| Heterodimeric antibodies that bind CD3 and tumor antigens Grant 11,225,528 - Bernett , et al. January 18, 2 | 2022-01-18 |
| Bispecific Antibodies That Bind to CD38 and CD3 App 20210309762 - Bernett; Matthew ; et al. | 2021-10-07 |
| Heterodimeric antibodies that bind CD3 and tumor antigens Grant 11,111,315 - Bernett , et al. September 7, 2 | 2021-09-07 |
| Heterodimeric Antibodies That Bind Fibroblast Activation Protein App 20210253736 - Desjarlais; John ; et al. | 2021-08-19 |
| Modulation of T cells with bispecific antibodies and Fc fusions Grant 11,091,548 - Bernett , et al. August 17, 2 | 2021-08-17 |
| Heterodimeric antibodies that bind fibroblast activation protein Grant 10,982,006 - Desjarlais , et al. April 20, 2 | 2021-04-20 |
| Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20210102003 - Bernett; Matthew J. ; et al. | 2021-04-08 |
| Heterodimeric antibodies that bind CD3 and tumor antigens Grant 10,913,803 - Bernett , et al. February 9, 2 | 2021-02-09 |
| Heterodimeric antibodies that bind CD3 and tumor antigens Grant 10,889,653 - Bernett , et al. January 12, 2 | 2021-01-12 |
| Modulation Of T Cells With Bispecific Antibodies And Fc Fusions App 20200339624 - Chu; Seung ; et al. | 2020-10-29 |
| Heterodimeric Antibodies That Bind Enpp3 And Cd3 App 20200317814 - Rashid; Rumana ; et al. | 2020-10-08 |
| Heterodimeric Antibodies That Bind Cd3 And Psma App 20200216559 - Moore; Gregory ; et al. | 2020-07-09 |
| Heterodimeric Antibodies That Bind Fibroblast Activation Protein App 20200165356 - Desjarlais; John ; et al. | 2020-05-28 |
| Targeting regulatory T cells with heterodimeric proteins Grant 10,544,187 - Chu , et al. Ja | 2020-01-28 |
| Heterodimeric antibodies that bind CD3 and CD38 Grant 10,526,417 - Bernett , et al. J | 2020-01-07 |
| Targeting regulatory T cells with heterodimeric proteins Grant 10,519,242 - Chu , et al. Dec | 2019-12-31 |
| Trispecific Antibodies App 20190352416 - Moore; Gregory ; et al. | 2019-11-21 |
| Trispecific antibodies Grant 10,428,155 - Moore , et al. October 1, 2 | 2019-10-01 |
| Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20190202938 - Bernett; Matthew J. ; et al. | 2019-07-04 |
| Modulation Of T Cells With Bispecific Antibodies And Fc Fusions App 20190194325 - Bernett; Matthew ; et al. | 2019-06-27 |
| Heterodimeric antibodies that bind CD3 and tumor antigens Grant 10,259,887 - Bernett , et al. | 2019-04-16 |
| Heterodimeric antibodies that bind CD3 and PSMA Grant 10,227,410 - Moore , et al. | 2019-03-12 |
| Modulation of T cells with bispecific antibodies and FC fusions Grant 10,227,411 - Bernett , et al. | 2019-03-12 |
| Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20180282432 - Bernett; Matthew J. ; et al. | 2018-10-04 |
| Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20180223000 - Bernett; Matthew J. ; et al. | 2018-08-09 |
| Heterodimeric antibodies to CD3 X CD123 Grant 9,856,327 - Bernett , et al. January 2, 2 | 2018-01-02 |
| Heterodimeric antibodies to CD3 X CD20 Grant 9,850,320 - Bernett , et al. December 26, 2 | 2017-12-26 |
| Bispecific antibodies that bind to CD38 and CD3 Grant 9,822,186 - Bernett , et al. November 21, 2 | 2017-11-21 |
| Heterodimeric Antibodies That Bind Cd3 And Psma App 20170320947 - Moore; Gregory ; et al. | 2017-11-09 |
| Heterodimeric Antibodies To Cd3 X Cd123 App 20170081424 - Bernett; Matthew J. ; et al. | 2017-03-23 |
| Heterodimeric Antibodies To Cd3 X Cd123 App 20170081420 - Bernett; Matthew J. ; et al. | 2017-03-23 |
| Modulation Of T Cells With Bispecific Antibodies And Fc Fusions App 20170037131 - Bernett; Matthew ; et al. | 2017-02-09 |
| Trispecific antibodies App 20160355600 - Moore; Gregory ; et al. | 2016-12-08 |
| Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20160355608 - Bernett; Matthew J. ; et al. | 2016-12-08 |
| Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20160229924 - Bernett; Matthew J. ; et al. | 2016-08-11 |
| Heterodimeric Antibodies That Bind Cd3 And Cd38 App 20160215063 - Bernett; Matthew J. ; et al. | 2016-07-28 |
| Heterodimeric Antibodies Including Binding To Cd8 App 20160176969 - Bernett; Matthew J. ; et al. | 2016-06-23 |
| Bispecific antibodies that bind to CD38 and CD3 App 20150307629 - Bernett; Matthew ; et al. | 2015-10-29 |
| Targeting Regulatory T Cells With Heterodimeric Proteins App 20140294836 - Chu; Seung ; et al. | 2014-10-02 |
| Targeting Regulatory T Cells With Heterodimeric Proteins App 20140294759 - Chu; Seung ; et al. | 2014-10-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 